Q2 2024 ImpediMed Ltd Activities Report Call Transcript
Thank you for standing by, and welcome to the ImpediMed Limited 4C conference call. (Operator Instructions)
I would now like to turn the conference over to Dr. Parmjot Bains, Interim CEO and Managing Director. Please go ahead.
Thank you. Good morning, and welcome to the ImpediMed investor call for the second quarter of fiscal 2024. My name is Parmjot Bains. It's good to meet you all virtually. I've been recently appointed Interim CEO and Managing Director of ImpediMed. And with me today is McGregor Grant, who is the Interim CFO and Executive Chairman of the company.
I'm sure as much of you are aware, McGregor and I were appointed to our respective executive roles at ImpediMed at the end of November 2023. And I only commenced on January 8 this year, so this is still very early days for us.
What I would like to do on this call is, firstly, introduce myself and provide a bit of background on my experience in life sciences and in the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |